CAS 491833-29-5
:N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide
Description:
N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide, with CAS number 491833-29-5, is a synthetic organic compound characterized by its complex structure, which includes a benzodioxin moiety and a pyrrolidine group. This compound is typically classified as an amide due to the presence of the octanamide functional group. Its stereochemistry is defined by the (1R,2R) configuration, indicating specific spatial arrangements of its atoms, which can influence its biological activity and interactions. The presence of hydroxyl and amine functional groups suggests potential for hydrogen bonding, which may enhance solubility in polar solvents. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry, particularly in the development of therapeutic agents. Its unique structural features could contribute to specific biological activities, although detailed studies would be necessary to elucidate its mechanisms of action and potential applications. As with many synthetic compounds, safety and handling precautions should be observed due to potential toxicity or reactivity.
Formula:C23H36N2O4
InChI:InChI=1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/t19-,23-/m1/s1
InChI key:InChIKey=FJZZPCZKBUKGGU-AUSIDOKSSA-N
SMILES:[C@@H]([C@@H](CN1CCCC1)NC(CCCCCCC)=O)(O)C=2C=C3C(=CC2)OCCO3
Synonyms:- Cerdelga
- Octanamide, N-[(1R,2R)-2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-
- Genz 99067
- N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-octanamide
- N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide
- Eliglustat
- GENZ-99067; GENZ99067; GENZ 99067
- GENZ-99067;GENZ99067;GENZ 99067;ELIGLUSTAT TARTRATE;GENZ-112638
- N-[(1r,2r)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide
- Elli Gustast
- pyrrolidinyl)-2-propanyl]octanamide
- CS-1540
- N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1-
- Eliglustat(Genz-99067)
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Eliglustat
CAS:Eliglustat (Genz 99067) is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease.Formula:C23H36N2O4Purity:99% - 99.70%Color and Shape:SolidMolecular weight:404.54Eliglustat
CAS:<p>Eliglustat is an oral medication used as a substrate reduction therapy for Gaucher disease type 1, which is an inherited lysosomal storage disorder. This product is a small-molecule inhibitor derived via chemical synthesis. Its primary mode of action involves the selective inhibition of glucosylceramide synthase, an enzyme responsible for the first committed step in glycosphingolipid biosynthesis. By reducing the production of glucosylceramide, eliglustat decreases the substrate accumulation that contributes to the pathophysiology of Gaucher disease.</p>Formula:C23H36N2O4Purity:Min. 97 Area-%Color and Shape:White PowderMolecular weight:404.54 g/molEliglustat-d15
CAS:Controlled ProductFormula:C23H21D15N2O4Color and Shape:NeatMolecular weight:419.64Eliglustat
CAS:Controlled Product<p>Applications Eliglustat is a specific and potent inhibitor of glucosylceramide synthase.<br>References Lukina Elena., et al.: Blood, 116, 893 (2010); McEachern Kerry Anne., et al.: Mol Genet Metab Rep., 91, 259 (2007);<br></p>Formula:C23H36N2O4Color and Shape:NeatMolecular weight:404.54





